Optimization of Diagnosis-Related Groups for 14,246 Patients with Uterine Leiomyoma in a Single Center in Western China Using a Machine Learning Model.

decision tree diagnosis-related groups uterine leiomyoma

Journal

Risk management and healthcare policy
ISSN: 1179-1594
Titre abrégé: Risk Manag Healthc Policy
Pays: England
ID NLM: 101566264

Informations de publication

Date de publication:
2024
Historique:
received: 29 09 2023
accepted: 23 02 2024
medline: 6 3 2024
pubmed: 6 3 2024
entrez: 6 3 2024
Statut: epublish

Résumé

Uterine leiomyoma (UL) is one of the most common benign tumors in women, and its incidence is gradually increasing in China. The clinical complications of UL have a negative impact on women's health, and the cost of treatment poses a significant burden on patients. Diagnosis-related groups (DRG) are internationally recognized as advanced healthcare payment management methods that can effectively reduce costs. However, there are variations in the design and grouping rules of DRG policies across different regions. Therefore, this study aims to analyze the factors influencing the hospitalization costs of patients with UL and optimize the design of DRG grouping schemes to provide insights for the development of localized DRG grouping policies. The Mann-Whitney Age, occupation, number of hospitalizations, type of medical insurance, Transfer to other departments, length of stay (LOS), type of UL, admission condition, comorbidities and complications, type of primary procedure, other types of surgical procedures, and discharge method had a significant impact on hospitalization costs (P<0.05). Among them, the type of primary procedure, other types of surgical procedures, and LOS were the main factors influencing hospitalization costs. By incorporating the type of primary procedure, other types of surgical procedures, and LOS into the decision tree model, patients were divided into 11 DRG combinations. Hospitalization costs for UL are mainly related to the type of primary procedure, other types of surgical procedures, and LOS. The DRG case combinations of UL based on E-CHAID algorithm are scientific and reasonable.

Sections du résumé

Background UNASSIGNED
Uterine leiomyoma (UL) is one of the most common benign tumors in women, and its incidence is gradually increasing in China. The clinical complications of UL have a negative impact on women's health, and the cost of treatment poses a significant burden on patients. Diagnosis-related groups (DRG) are internationally recognized as advanced healthcare payment management methods that can effectively reduce costs. However, there are variations in the design and grouping rules of DRG policies across different regions. Therefore, this study aims to analyze the factors influencing the hospitalization costs of patients with UL and optimize the design of DRG grouping schemes to provide insights for the development of localized DRG grouping policies.
Methods UNASSIGNED
The Mann-Whitney
Results UNASSIGNED
Age, occupation, number of hospitalizations, type of medical insurance, Transfer to other departments, length of stay (LOS), type of UL, admission condition, comorbidities and complications, type of primary procedure, other types of surgical procedures, and discharge method had a significant impact on hospitalization costs (P<0.05). Among them, the type of primary procedure, other types of surgical procedures, and LOS were the main factors influencing hospitalization costs. By incorporating the type of primary procedure, other types of surgical procedures, and LOS into the decision tree model, patients were divided into 11 DRG combinations.
Conclusion UNASSIGNED
Hospitalization costs for UL are mainly related to the type of primary procedure, other types of surgical procedures, and LOS. The DRG case combinations of UL based on E-CHAID algorithm are scientific and reasonable.

Identifiants

pubmed: 38444948
doi: 10.2147/RMHP.S442502
pii: 442502
pmc: PMC10913598
doi:

Types de publication

Journal Article

Langues

eng

Pagination

473-485

Informations de copyright

© 2024 Ma et al.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Yuan Ma (Y)

Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, People's Republic of China.

Li Li (L)

Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Li Yu (L)

Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Wei He (W)

Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Ling Yi (L)

Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Yuxin Tang (Y)

Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Jijie Li (J)

Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Zhigang Zhong (Z)

Department of Prevention, Office of Cancer Prevention and Treatment, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China.

Meixian Wang (M)

National Center for Birth Defects Monitoring, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Shiyao Huang (S)

Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu, Sichuan, People's Republic of China.

Yiquan Xiong (Y)

Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu, Sichuan, People's Republic of China.

Pei Xiao (P)

Medical Insurance Office, West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Yuxiang Huang (Y)

Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Classifications MeSH